Chronic severe asthma affects only a subsegment of patients with asthma and is characterized, in part, by persistent airflow obstruction and symptoms despite ongoing treatment. Because of the severity of their disease, this population of asthmatic patients has the greatest morbidity and health care costs. At present, the mechanisms that cause severe asthma are not fully established. The overall goal of this research project is to define the features of severe asthma, identify the mechanisms that lead to this phenotype and discover possible inroads for new and more effective therapies. Based upon existing evidence and preliminary data, it is the hypothesis of this research project that severe asthma is caused, in some patients, by a persistent respiratory infection by viruses (i.e. rhinovirus, respiratory syncytial virus, or adenovirus), Mycoplasma pneumonia, or Chlamydia pneumonia. It is further proposed that these agents infect lower airway epithelium and macrophages to enhance the production of inflammatory cytokines/chemokines (i.e. IL-8) and recruitment of inflammatory cells, particularly neutrophils, to further airway injury and airflow obstruction. To accomplish these goals, subjects with severe asthma (i.e. FEV1 <75% predicted, and ongoing symptoms despite high doses of inhaled corticosteroids) will be recruited along with three groups for comparison: Mild asthma, asthma with airflow obstruction, i.e. FEV, <75% predicted, but reversible to beta agonists, and normals. Measurements of preliminary physiology will be made in these four groups to test the hypothesis that severe asthma is characterized by airway-parenchymal uncoupling. In addition, imaging techniques will be used to correlate determinants of pulmonary physiology with airway structure, by high resolution computerized tomography, and ventilation abnormalities, by magnetic resonance imaging with inhaled hyperpolarized helium. To determine the characteristics of inflammation in peripheral blood, sputum, and lavage fluid, mucosal biopsies will be obtained to assess the hypothesis that neutrophilic inflammation and IL-8 are characteristic features of fixed airway obstruction in severe asthma whereas eosinophilic injury and IL-5 are associated more with reversible airway obstruction. Finally, PCR and immunohistochemistry of lavage fluid and mucosal biopsies will be used to test the hypothesis that severe asthma and fixed airway obstruction with IL-8 and neutrophils are associated with a persistent respiratory infection by respiratory viruses (i.e. adenovirus, influenza, respiratory syncytial virus or rhinovirus), Mycoplasma pneumonia, or Chlamydia pneumonia. It is proposed that these studies will provide new insights into mechanisms of asthma, and particularly severe persistent disease, and potential new approaches to treatment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069116-04
Application #
6775552
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Program Officer
Noel, Patricia
Project Start
2001-09-20
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
4
Fiscal Year
2004
Total Cost
$509,250
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Zha, Wei; Kruger, Stanley J; Cadman, Robert V et al. (2018) Regional Heterogeneity of Lobar Ventilation in Asthma Using Hyperpolarized Helium-3 MRI. Acad Radiol 25:169-178
Mummy, David G; Kruger, Stanley J; Zha, Wei et al. (2018) Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma. J Allergy Clin Immunol 141:1140-1141.e4
Evans, Michael D; Esnault, Stephane; Denlinger, Loren C et al. (2018) Sputum cell IL-1 receptor expression level is a marker of airway neutrophilia and airflow obstruction in asthmatic patients. J Allergy Clin Immunol 142:415-423
Choi, Sanghun; Haghighi, Babak; Choi, Jiwoong et al. (2017) Differentiation of quantitative CT imaging phenotypes in asthma versus COPD. BMJ Open Respir Res 4:e000252
Choi, Sanghun; Hoffman, Eric A; Wenzel, Sally E et al. (2017) Quantitative computed tomographic imaging-based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes. J Allergy Clin Immunol 140:690-700.e8
Modena, Brian D; Bleecker, Eugene R; Busse, William W et al. (2017) Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease. Am J Respir Crit Care Med 195:1449-1463
Gomez, Jose L; Yan, Xiting; Holm, Carole T et al. (2017) Characterisation of asthma subgroups associated with circulating YKL-40 levels. Eur Respir J 50:
Hahn, Andrew D; Cadman, Robert V; Sorkness, Ronald L et al. (2016) Redistribution of inhaled hyperpolarized 3He gas during breath-hold differs by asthma severity. J Appl Physiol (1985) 120:526-36
Esnault, Stephane; Kelly, Elizabeth A; Sorkness, Ronald L et al. (2016) Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients. J Allergy Clin Immunol 137:767-73.e6
Johansson, Mats W; Evans, Michael D; Crisafi, Gina M et al. (2016) Serum periostin is associated with type 2 immunity in severe asthma. J Allergy Clin Immunol 137:1904-1907.e2

Showing the most recent 10 out of 78 publications